NEW YORK (GenomeWeb News) - Solexa has been added to the Russell 3000 Index, which measures the performance of the 3,000 largest US companies based on total market capitalization, the company said today.
 
Inclusion in the index "should increase Solexa's visibility with institutions that rely on it as part of their investment strategy," said John West, Solexa CEO, in a statement.
 
Solexa's market cap is currently $324 million.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The US National Institutes of Health and the Food and Drug Administration have proposed changing gene therapy oversight, the Associated Press reports.

Nature News reports that the Salk Institute has asked for the scope of a gender discrimination lawsuit brought against it to be narrowed.

CNBC reports that the sequencing startup Veritas aims to sequence individuals who fall at extremes.

In PLOS this week: genotyping of indigenous North African goats, program to simulate evolve and resequencing studies, and more.

Sep
17
Sponsored by
SeraCare

Today’s challenging clinical next-generation sequencing applications require a rigorous, comprehensive quality control management program to ensure confidence in results.